Drug Design Development and Therapy
Interpreting Model-Informed Recommendations for Initial Tacrolimus Dosing in Membranous Nephropathy [Letter]
By Wenjing Fu and Jingyu Wang.
Abstract
Wenjing Fu,1 Jingyu Wang21Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, 621000, People’s Republic of China; 2Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Institute of Nephrology, Zhejiang University, Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, People’s Republic of ChinaCorrespondence: Jingyu Wang, Email cqfl_wjy@163.com
Keywords
- Renal Transplantation Outcomes and Treatments
- tacrolimus
- membranous nephropathy
- initial dose
- pharmacokinetic modeling
- model-informed dosing
- immunosuppressive therapy
- Open access
Source
Published in Drug Design Development and Therapy. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
